JWH-030
From Wikipedia, the free encyclopedia
|
JWH-030
|
|
| Systematic (IUPAC) name | |
| naphthalen-1-yl-(1-pentylpyrrol-3-yl)methanone | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C20H21NO |
| Mol. mass | 291.386 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
JWH-030 is a drug which is a cannabinoid receptor agonist.[1] It has analgesic effects and is used in scientific research.[2] It is a partial agonist at CB1 receptors, with a Ki of 87nM, making it around half the potency of THC.[3]
[edit] References
- ^ Lainton JAH, Huffman JW, Martin BR, Compton DR. Tetrahedron Letters. 1995; 36:1401.
- ^ Pertwee RG, Griffin, G, Lainton JAH, Huffman JW. European Journal of Pharmacology. 1995; 284:241.
- ^ Griffin G, Atkinson PJ, Showalter VM, Martin BR, Abood ME. Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes. Journal of Pharmacology and Experimental Therapeutics. 1998 May;285(2):553-60. PMID 9580597
|
|||||||||||||||||||||||||||||||||||||

